Bio-imaging and Photodynamic Therapy with Tetra Sulphonatophenyl Porphyrin (TSPP)-TiO 2 Nanowhiskers: New Approaches in Rheumatoid Arthritis Theranostics

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zhao, Chunqiu ^a   Ur Rehman, Fawad ^b   Yang, Yanlong ^c   Li, Xiaoqi ^d   Zhang, Dong ^b   Jiang, Hui ^b   Selke, Matthias ^a   Wang, Xuemei ^a   Liu, Chongyang ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

^d Nanjing Foreign Language School   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; NANOCOMPOSITE; PORPHYRIN; TITANIUM; TITANIUM DIOXIDE;

ANIMAL; ARTHRITIS, RHEUMATOID; BLOOD; DIAGNOSTIC IMAGING; DISEASE MODEL; FLUORESCENCE IMAGING; MALE; PHOTOCHEMOTHERAPY; PROCEDURES; RAT; THERANOSTIC NANOMEDICINE;

ANIMALS; ARTHRITIS, RHEUMATOID; CYTOKINES; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; MALE; NANOCOMPOSITES; OPTICAL IMAGING; PHOTOCHEMOTHERAPY; PORPHYRINS; RATS; THERANOSTIC NANOMEDICINE; TITANIUM;

EID: 84936972641     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11518     Document Type: Article

References (51)

1. Firestein, G. S. Evolving concepts of rheumatoid arthritis. Nature 423, 356-361, 10.1038/nature01661 (2003)
2. Klareskog, L., Padyukov, L. &Alfredsson, L. Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol 19, 49-54, 10.1097/BOR.0b013e32801127c8 (2007)
3. Schuna, A. A. Update on treatment of rheumatoid arthritis. J Am Pharm Assoc (Wash) 38, 728-735; quiz 735-727 (1997)
4. Chen, L., Bao, B., Wang, N., Xie, J. &Wu, W. Oral Administration of Shark Type II Collagen Suppresses Complete Freund's Adjuvant-Induced Rheumatoid Arthritis in Rats. Pharmaceuticals 5, 339-352, 10.3390/ph5040339 (2012)
5. McInnes, I. B. &Schett, G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7, 429-442, 10.1038/ nri2094 (2007)
6. Kinne, R. W., Brauer, R., Stuhlmuller, B., Palombo-Kinne, E. &Burmester, G. R. Macrophages in rheumatoid arthritis. Arthritis Res 2, 189-202, 10.1186/ar86 (2000)
7. Meyer, L. H., Franssen, L. &Pap, T. The role of mesenchymal cells in the pathophysiology of inflammatory arthritis. Best Pract Res Clin Rheumatol 20, 969-981, 10.1016/j.berh.2006.06.005 (2006)
8. Buckley, C. D., Filer, A., Haworth, O., Parsonage, G. &Salmon, M. Defining a role for fibroblasts in the persistence of chronic inflammatory joint disease. Ann Rheum Dis 63 Suppl 2, ii92-ii95, 10.1136/ard.2004.028332 (2004)
9. Brennan, F. M., Maini, R. N. &Feldmann, M. TNF alpha-A pivotal role in rheumatoid arthritis? Br J Rheumatol 31, 293-298 (1992)
10. Koch, A. E. et al. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152, 4149-4156 (1994)
11. Chabaud, M. et al. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42, 963-970, 10.1002/1529-0131(199905)42:5 963::AID-ANR15 3.0.CO;2-E (1999)
12. Ziolkowska, M. et al. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 164, 2832-2838 (2000)
13. Bush, K. A., Farmer, K. M., Walker, J. S. &Kirkham, B. W. Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein. Arthritis Rheum 46, 802-805, 10.1002/art.10173 (2002)
14. Ion, R.-M. Porphyrins for tumor destruction in photodynamic therapy. Current topics in Biophysics 24, 21-34 (2000)
15. Dougherty, T. J. et al. Photodynamic therapy. J Natl Cancer Inst 90, 889-905 (1998)
16. Torring, T., Helmig, S., Ogilby, P. R. &Gothelf, K. V. Singlet oxygen in DNA nanotechnology. Acc Chem Res 47, 1799-1806, 10.1021/ar500034y (2014)
17. Daicoviciu, D. et al. Oxidative photodamage induced by photodynamic therapy with methoxyphenyl porphyrin derivatives in tumour-bearing rats. Folia Biol (Praha) 57, 12-19 (2011)
18. Sharman, W. M., Allen, C. M. &van Lier, J. E. Photodynamic therapeutics: basic principles and clinical applications. Drug Discov Today 4, 507-517 (1999)
19. Alexandrova, R. et al. in Temp Symposium Entry. 227-234 (International Society for Optics and Photonics)
20. Wang, J. et al. In vivo self-bio-imaging of tumors through in situ biosynthesized fluorescent gold nanoclusters. Sci Rep 3, 1157, doi:10.1038/srep01157 (2013)
21. Xu, J. et al. Photokilling cancer cells using highly cell-specific antibody-TiO(2) bioconjugates and electroporation. Bioelectrochemistry 71, 217-222, 10.1016/j.bioelechem.2007.06.001 (2007)
22. Cheng, K. et al. Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting. Nat Commun 5, 4880, 10.1038/ ncomms5880 (2014)
23. Tsuang, Y. H. et al. Studies of photokilling of bacteria using titanium dioxide nanoparticles. Artif Organs 32, 167-174, 10.1111/j.1525-1594.2007.00530.x (2008)
24. Li, Y. et al. A smart and versatile theranostic nanomedicine platform based on nanoporphyrin. Nat Commun 5, 4712, 10.1038/ncomms5712 (2014)
25. Konaka, R. et al. Irradiation of titanium dioxide generates both singlet oxygen and superoxide anion. Free Radical Biology and Medicine 27, 294-300, 10.1016/s0891-5849(99)00050-7 (1999)
26. Buchalska, M. et al. New insight into singlet oxygen generation at surface modified nanocrystalline TiO2-The effect of nearinfrared irradiation. Dalton Transactions 42, 9468-9475, 10.1039/c3dt50399b (2013)
27. Bai, Y. et al. Stability of Pt nanoparticles and enhanced photocatalytic performance in mesoporous Pt-(anatase/TiO2 (B)) nanoarchitecture. J Mater Chem 19, 7055-7061 (2009)
28. Jin, X. &Kusumoto, Y. Spectroscopic studies of pyrene adsorbed to titanium dioxide. Chemical physics letters 378, 192-194 (2003)
29. Song, M. et al. The in vitro inhibition of multidrug resistance by combined nanoparticulate titanium dioxide and UV irradition. Biomaterials 27, 4230-4238, 10.1016/j.biomaterials.2006.03.021 (2006)
30. Setyawati, M. I. et al. Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherin. Nat Commun 4, 1673, 10.1038/ncomms2655 (2013)
31. Li, Q. et al. The incorporation of daunorubicin in cancer cells through the use of titanium dioxide whiskers. Biomaterials 30, 4708-4715, 10.1016/j.biomaterials.2009.05.015 (2009)
32. Feldmann, M. Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol 2, 364-371, 10.1038/nri802 (2002)
33. Van Parijs, L. &Abbas, A. K. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 280, 243-248 (1998)
34. Ehrenstein, M. R. et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200, 277-285, 10.1084/jem.20040165 (2004)
35. Neupane, J., Ghimire, S., Shakya, S., Chaudhary, L. &Shrivastava, V. P. Effect of light emitting diodes in the photodynamic therapy of rheumatoid arthritis. Photodiagnosis Photodyn Ther 7, 44-49, 10.1016/j.pdpdt.2009.12.006 (2010)
36. De Jong, W. H. &Borm, P. J. Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine 3, 133-149 (2008)
37. Davila, J. &Harriman, A. Photoreactions of macrocyclic dyes bound to human serum albumin. Photochem Photobiol 51, 9-19 (1990)
38. Van bezooijen, R. L., Farih-Sips, H. C., Papapoulos, S. E. &Lowik, C. W. Interleukin-17: A new bone acting cytokine in vitro. J Bone Miner Res 14, 1513-1521, 10.1359/jbmr.1999.14.9.1513 (1999)
39. Lubberts, E., Koenders, M. I. &van den Berg, W. B. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther 7, 29-37, 10.1186/ar1478 (2005)
40. Gilroy, D. W., Lawrence, T., Perretti, M. &Rossi, A. G. Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 3, 401-416, 10.1038/nrd1383 (2004)
41. Brady, H. R. et al. Lipoxygenase product formation and cell adhesion during neutrophil-glomerular endothelial cell interaction. Am J Physiol 268, F1-12 (1995)
42. Zvaifler, N. J. &Firestein, G. S. Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis. Arthritis Rheum 37, 783-789 (1994)
43. Salmon, M. et al. Inhibition of T cell apoptosis in the rheumatoid synovium. J Clin Invest 99, 439-446, 10.1172/JCI119178 (1997)
44. Kuimova, M. K., Yahioglu, G. &Ogilby, P. R. Singlet oxygen in a cell: spatially dependent lifetimes and quenching rate constants. J Am Chem Soc 131, 332-340, 10.1021/ja807484b (2009)
45. Kokkola, R. et al. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum 48, 2052-2058, 10.1002/art.11161 (2003)
46. Bendele, A. Animal models of rheumatoid arthritis. J Musculoskelet Neuronal Interact 1, 377-385 (2001)
47. Brand, D. D., Latham, K. A. &Rosloniec, E. F. Collagen-induced arthritis. Nat Protoc 2, 1269-1275, 10.1038/nprot.2007.173 (2007)
48. Parasuraman, S., Raveendran, R. &Kesavan, R. Blood sample collection in small laboratory animals. J Pharmacol Pharmacother 1, 87-93, 10.4103/0976-500X.72350 (2010)
49. Gabriel, D. et al. Thrombin-sensitive dual fluorescence imaging and therapeutic agent for detection and treatment of synovial inflammation in murine rheumatoid arthritis. J Control Release 163, 178-186, 10.1016/j.jconrel.2012.08.022 (2012)
50. Horwitz, E. M. et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A 99, 8932-8937, 10.1073/ pnas.132252399 (2002)
51. Tropel, P. et al. Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res 295, 395-406, 10.1016/j.yexcr.2003.12.030 (2004)